Reactive oxygen species–independent activation of the IL-1β inflammasome in cells from patients with chronic granulomatous disease
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Humans with chronic granulomatous diseases (CGDs) due to mutations in p47-phox have defective NADPH activity and thus cannot generate NADPH-dependent reactive oxygen species (ROS). The role of ROS in inflammation is controversial; some in vitro studies suggest that ROS are crucial for secretion of IL-1β via inflammasome activation, whereas mice defective for ROS and patients with CGD have a proinflammatory phenotype. In this study, we evaluated activation of the IL-1β inflammasome in cells from CGD patients. In contrast to previous studies using the small molecule diphenylene iodonium (DPI) as a ROS inhibitor, we found no decrease in either caspase-1 activation or secretion of IL-1β and IL-18 in primary CGD monocytes. Moreover, activation of CGD monocytes by uric acid crystals induced a 4-fold higher level of IL-1β secretion compared with that seen in monocytes from unaffected subjects, and this increase was not due to increased synthesis of the IL-1β precursor. In addition, Western blot analysis of CGD cells revealed that caspase-1 activation was not decreased, but rather was increased compared with control cells. Examination of the effects exerted by the inhibition of ROS activity by DPI revealed that the decrease in IL-1β secretion by DPI was actually due to inhibition of IL-1β gene expression. Thus, inconsistent with the proinflammatory role of ROS, the present findings support the concept that ROS likely dampen inflammasome activation. The absence of ROS in CGD monocytes may explain the presence of an inflammatory phenotype characterized by granulomas and inflammatory bowel disease occurring in CGD patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Three studies showed independently that Nox2 is completely dispensable for NLRP3 inflammasome activation in human macrophages.”
From Functions of ROS in Macrophages and Antimicrobial Immunity (2021) · cites this paper as [336]
In the citing paper
“Whole blood samples [335] or isolated PBMC [335,336,337] showed no alterations in levels of active caspase-1 or IL-1β/IL18 secretion after treatment with typical inflammasome-activating stimuli, such as LPS/ATP, silica or uric acid crystals.”
From Functions of ROS in Macrophages and Antimicrobial Immunity (2021) · cites this paper as [336]
Citations
Cites
Gout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326 · cited 2×
“The NLRP3 inflammasome has been reported to be activated by uric acid crystals (11, 20), and priming with a TLR stimulus such as LPS is required to accomplish this activation (21).”
BackgroundMethodInnate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica
Dostert, C., Pétrilli, V., Van Bruggen, R., Steele, C., Mossman, B. T., & Tschopp, J. (2008) · Science · doi:10.1126/science.1156995 · Cited by 2,658
Franchi, L., Eigenbrod, T., Muñoz-Planillo, R., & Nuñez, G. (2009) · Nature Immunology · doi:10.1038/ni.1703 · Cited by 1,834 · cited 2×
“Activation of caspase-1 by the protein complex known as the inflammasome leads to the conversion of proinflammatory IL-1β (pro-IL-1β) to IL-1β (9).”
BackgroundChronic Granulomatous Disease: Report on a National Registry of 368 Patients
Winkelstein, J. A., Marino, M. C., Johnston, R. B., Boyle, J., Curnutte, J., Gallin, J. I., Malech, H. L., Holland, S. M., Ochs, H., Quie, P., et al. (2000) · Medicine · doi:10.1097/00005792-200005000-00003 · Cited by 1,728 · cited 1×
“In line with this, patients with chronic granulomatous diseases (CGDs) with defects in the NADPH system and, consequently, defective ROS generation (17) display an inflammatory phenotype characterized by granulomas and Crohn-like colitis (18).”
BackgroundThe Nalp3 inflammasome is essential for the development of silicosis
Cassel, S. L., Eisenbarth, S. C., Iyer, S. S., Sadler, J. J., Colegio, O. R., Tephly, L. A., Carter, A. B., Rothman, P. B., Flavell, R. A., & Sutterwala, F. S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803933105 · Cited by 907 · cited 4×
“We found that DPI can indeed inhibit IL-1β production in human PBMCs, as reported previously in THP-1 cells and mouse macrophages (11, 14).”
BackgroundMethodResultInfluentialInflammasome adaptors and sensors: intracellular regulators of infection and inflammation
Mariathasan, S., & Monack, D. M. (2007) · Nature Reviews Immunology · doi:10.1038/nri1997 · Cited by 869 · cited 1×
“Several protein platforms/inflammasomes have been described for the activation of caspase-1, each of which includes members of the NOD-like receptor (NLR) family of proteins (10).”
BackgroundRedox Regulation of NF-kappa B Activation
Flohé, L., Brigelius-Flohé, R., Saliou, C., Traber, M. G., & Packer, L. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00501-1 · Cited by 859 · cited 1×
“Our data demonstrating that the anti-inflammatory effects of DPI on IL-1β production are exerted at the transcriptional level are in line with the large body of literature reporting that ROS induce NF-κB activation (12, 23, 24).”
BackgroundNetea, M. G., Nold-Petry, C. A., Nold, M. F., Joosten, L. A. B., Opitz, B., van der Meer, J. H. M., van de Veerdonk, F. L., Ferwerda, G., Heinhuis, B., Devesa, I., et al. (2009) · Blood · doi:10.1182/blood-2008-03-146720 · Cited by 792
Self-citationNetea, M. G. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27114 · Cited by 753 · cited 1×
“Separation and stimulation of PBMCs was performed as described previously (33).”
MethodSelf-citationHolmes, B., Page, A. R., & Good, R. A. (1967) · Journal of Clinical Investigation · doi:10.1172/jci105634 · Cited by 686 · cited 1×
“In line with this, patients with chronic granulomatous diseases (CGDs) with defects in the NADPH system and, consequently, defective ROS generation (17) display an inflammatory phenotype characterized by granulomas and Crohn-like colitis (18).”
BackgroundKabe, Y., Ando, K., Hirao, S., Yoshida, M., & Handa, H. (2005) · Antioxidants & Redox Signaling · doi:10.1089/ars.2005.7.395 · Cited by 585
Involvement of Reactive Oxygen Species in Toll-Like Receptor 4-Dependent Activation of NF-κB
Asehnoune, K., Strassheim, D., Mitra, S., Kim, J. Y., & Abraham, E. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.4.2522 · Cited by 562
Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease
Romani, L., Fallarino, F., De Luca, A., Montagnoli, C., D’Angelo, C., Zelante, T., Vacca, C., Bistoni, F., Fioretti, M. C., Grohmann, U., et al. (2008) · Nature · doi:10.1038/nature06471 · Cited by 535 · cited 1×
“On theother hand, other studies have reported anti-inflammatory effects of the NADPH system and ROS (15), and a recent study in mice defective for the generation of ROS strongly suggestedanti-inflammatory effects of oxygen species (16).”
BackgroundLi, Y., & Trush, M. A. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9729 · Cited by 478 · cited 1×
“DPI in a concentration of 10 μM was used as an ROS inhibitor (34).”
MethodStuehr, D. J., Fasehun, O. A., Kwon, N. S., Gross, S. S., Gonzalez, J. A., Levi, R., & Nathan, C. F. (1991) · The FASEB Journal · doi:10.1096/fasebj.5.1.1703974 · Cited by 464 · cited 1×
“Possible additional mechanisms modulated by DPI include inhibition of nitric oxide synthetase and mitochondrial complex 1-dependent (25, 26).”
BackgroundFranchi, L., & Núñez, G. (2008) · European Journal of Immunology · doi:10.1002/eji.200838549 · Cited by 450 · cited 1×
“One assay used stimulation for 3 hwith LPS, followed byATP-induced IL-1β release for 15min (35), and a second assay used specific stimulation with LPS-free monosodium urate, also known as uric acid crystals, a putative NLRP3 ligand (20).”
MethodSuperoxide dismutase 1 regulates caspase-1 and endotoxic shock
Meissner, F., Molawi, K., & Zychlinsky, A. (2008) · Nature Immunology · doi:10.1038/ni.1633 · Cited by 300 · cited 2×
“SOD-1–deficient mice produced less IL-1β in vivo and were less susceptible to LPS-induced shock (31).”
BackgroundGene Expression Profiling Provides Insight into the Pathophysiology of Chronic Granulomatous Disease
Kobayashi, S. D., Voyich, J. M., Braughton, K. R., Whitney, A. R., Nauseef, W. M., Malech, H. L., & DeLeo, F. R. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.1.636 · Cited by 178
Schäppi, M. G., Jaquet, V., Belli, D. C., & Krause, K. (2008) · Seminars in Immunopathology · doi:10.1007/s00281-008-0119-2 · Cited by 171 · cited 2×
“In addition to these arguments, it should be kept in mind that the concept that ROS induces inflammasome activation is at odds with the known proinflammatory phenotype of patients with CGD, characterized by the occurrence of sterile granulomas, colitis, and inflammatory skin and urogenital reactions, in which IL-1β is…”
BackgroundBodar, E. J., van der Hilst, J. C. H., Drenth, J. P. H., van der Meer, J. W. M., & Simon, A. (2005) · PubMed · Cited by 166
Giamarellos‐Bourboulis, E. J., Mouktaroudi, M., Bodar, E. J., van der Ven, J., Kullberg, B.-J., Netea, M. G., & van der Meer, J. W. M. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.082222 · Cited by 149 · cited 1×
“The NLRP3 inflammasome has been reported to be activated by uric acid crystals (11, 20), and priming with a TLR stimulus such as LPS is required to accomplish this activation (21).”
BackgroundSelf-citationAutoinflammatory Diseases: Clinical and Genetic Advances
Farasat, S., Aksentijevich, I., & Toro, J. R. (2008) · Archives of Dermatology · doi:10.1001/archderm.144.3.392 · Cited by 143 · cited 1×
“Blood monocytes from patients with some of these disorders, especially cryopyrinopathies and HIDS, readily release more IL-1β than do monocytes from unaffected controls (7, 8).”
BackgroundMoser, C. E., Pohl, G., Haslinger, I., Knapp, S., Rowczenio, D. M., Russel, T., Lachmann, H. J., Lang, U., & Kovarik, J. (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn646 · Cited by 132 · cited 1×
“T is much recent interest in the processing and release of bioactive IL-1β, especially since the discovery that blockade of IL-1 receptors with the IL-1 receptor antagonist (IL-1Ra) is a very effective treatment for autoinflammatory disorders, such as familial Mediterranean fever (1), familial cold autoinflammatory sy…”
Backgroundp47 phox Deficiency Impairs NF-κB Activation and Host Defense in Pseudomonas Pneumonia
Sadikot, R. T., Zeng, H., Yull, F. E., Li, B., Cheng, D.-S., Kernodle, D. S., Jansen, E. D., Contag, C. H., Segal, B. H., Holland, S. M., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.3.1801 · Cited by 108
Kalliolias, G. D., & C Liossis, S.-N. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.3.349 · Cited by 102 · cited 1×
“T is much recent interest in the processing and release of bioactive IL-1β, especially since the discovery that blockade of IL-1 receptors with the IL-1 receptor antagonist (IL-1Ra) is a very effective treatment for autoinflammatory disorders, such as familial Mediterranean fever (1), familial cold autoinflammatory sy…”
BackgroundLekstrom-Himes, J. A., Kuhns, D. B., Alvord, W. G., & Gallin, J. I. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.1.411 · Cited by 96
Pathogen-Induced Interleukin-1β Processing and Secretion Is Regulated by a Biphasic Redox Response
Tassi, S., Carta, S., Vené, R., Delfino, L., Ciriolo, M. R., & Rubartelli, A. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900578 · Cited by 96 · cited 1×
“Another recent study demonstrated that silencing SOD-1 in human monocytes results in a reduction of IL-1β secretion on stimulation with zymosan (32).”
BackgroundYamazaki, T., Masumoto, J., Agematsu, K., Sawai, N., Kobayashi, S., Shigemura, T., Yasui, K., & Koike, K. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23261 · Cited by 67 · cited 1×
“T is much recent interest in the processing and release of bioactive IL-1β, especially since the discovery that blockade of IL-1 receptors with the IL-1 receptor antagonist (IL-1Ra) is a very effective treatment for autoinflammatory disorders, such as familial Mediterranean fever (1), familial cold autoinflammatory sy…”
BackgroundDrenth, J. P. H., van der Meer, J. W., & Kushner, I. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.1.400 · Cited by 62 · cited 1×
“Blood monocytes from patients with some of these disorders, especially cryopyrinopathies and HIDS, readily release more IL-1β than do monocytes from unaffected controls (7, 8).”
BackgroundKwon, K. H., Ohigashi, H., & Murakami, A. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.05.022 · Cited by 56 · cited 1×
“Those studies were based on the use of ROS inhibitors such as DPI in cell lines or mouse macrophages, however (11, 14, 22).”
MethodHutchinson, D. S., Csikasz, R. I., Yamamoto, D. L., Shabalina, I. G., Wikström, P., Wilcke, M., & Bengtsson, T. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.02.006 · Cited by 50 · cited 1×
“Possible additional mechanisms modulated by DPI include inhibition of nitric oxide synthetase and mitochondrial complex 1-dependent (25, 26).”
BackgroundWarris, A., Netea, M. G., Wang, J. E., Gaustad, P., Kullberg, B. J., Verweij, P. E., & Abrahamsen, T. G. (2003) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540310013009 · Cited by 42
Self-citationHatanaka, E., Costa‐Carvalho, B. T., Condino‐Neto, A., & Čampa, A. (2004) · Immunology Letters · doi:10.1016/j.imlet.2004.04.016 · Cited by 41
Response to IL‐1‐Receptor Antagonist in a Child with Familial Cold Autoinflammatory Syndrome
O'Connell, S. M., O’Regan, G. M., Bolger, T., Hoffman, H. M., Cant, A. J., Irvine, A. D., & Watson, R. M. (2007) · Pediatric Dermatology · doi:10.1111/j.1525-1470.2007.00343.x · Cited by 31 · cited 1×
“T is much recent interest in the processing and release of bioactive IL-1β, especially since the discovery that blockade of IL-1 receptors with the IL-1 receptor antagonist (IL-1Ra) is a very effective treatment for autoinflammatory disorders, such as familial Mediterranean fever (1), familial cold autoinflammatory sy…”
BackgroundAnakinra for the treatment of neonatal-onset multisystem inflammatory disease
Hoffman, H. M., & Firestein, G. S. (2006) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0350 · Cited by 9 · cited 1×
“T is much recent interest in the processing and release of bioactive IL-1β, especially since the discovery that blockade of IL-1 receptors with the IL-1 receptor antagonist (IL-1Ra) is a very effective treatment for autoinflammatory disorders, such as familial Mediterranean fever (1), familial cold autoinflammatory sy…”
Background
Cited by
Type 2 diabetes as an inflammatory disease
Donath, M. Y., & Shoelson, S. E. (2011) · Nature Reviews Immunology · doi:10.1038/nri2925 · Cited by 3,737
“β-cells have very low levels of antioxidative enzymes and are therefore particularly vulnerable to oxidative stress; however, activation of the inflammasome in the absence of reactive oxygen species has been shown in patients with chronic granulomatous diseas”
BackgroundActivation and regulation of the inflammasomes
Latz, E., Xiao, T. S., & Stutz, A. (2013) · Nature Reviews Immunology · doi:10.1038/nri3452 · Cited by 2,884
Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
Dinarello, C. A. (2011) · Blood · doi:10.1182/blood-2010-07-273417 · Cited by 2,248
Self-citationMolecular mechanisms regulating NLRP3 inflammasome activation
Jo, E.-K., Kim, J. K., Shin, D.-M., & Sasakawa, C. (2016) · Cellular & Molecular Immunology · doi:10.1038/cmi.2015.95 · Cited by 1,378
Masters, S. L., Dunne, A., Subramanian, S. L., Hull, R. L., Tannahill, G. M., Sharp, F. A., Becker, C., Franchi, L., Yoshihara, E., Chen, Z., et al. (2010) · Nature Immunology · doi:10.1038/ni.1935 · Cited by 1,330
“Papers have shown that patients deficient in ROS production still activate the inflammasome to an even greater degree than do healthy controls with normal ROS productio”
Background
Metadata
- Authors
- van de Veerdonk, F. L., Smeekens, S. P., Joosten, L. A. B., Kullberg, B. J., Dinarello, C. A., van der Meer, J. W. M., & Netea, M. G.
- Affiliations
- Department of Medicine, Radboud University Nijmegen Medical Center and Nijmegen Institute for Infection, Inflammation, and Immunity (N4i), 6500 HB Nijmegen, The Netherlands
- Radboud University Nijmegen (NL)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2010-01-26
- Volume
- 107
- Issue
- 7
- Pages
- 3030-3033
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2840365
- OpenAlex
- W2107640432
- Cited by
- 248
- References
- 35
- Citations by year
- 2026: 3 · 2025: 9 · 2024: 8 · 2023: 8 · 2022: 4 · 2021: 12 · 2020: 12 · 2019: 13 · 2018: 12 · 2017: 13 · 2016: 19 · 2015: 17 · 2014: 19 · 2013: 28 · 2012: 28
- FWCI
- 12.91
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Immunology and Microbiology › Immunology › Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- chronic granulomatous disease, reactive oxygen species, p47phox, NADPH oxidase, caspase-1 activation, IL-1β secretion, IL-18, monocytes, urate crystals, diphenyleneiodonium, inflammation, granuloma, inflammatory bowel disease
- MeSH terms
- Catecholamines, Gene Expression Regulation, Granulomatous Disease, Chronic, Humans, Inflammation, Monocytes, Blotting, Western, Cytokines, Reactive Oxygen Species, Statistics, Nonparametric, Reverse Transcriptase Polymerase Chain Reaction, Caspase 1, Imidazolines, Interleukin-1beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.